United States: Digital Health Law Update, Vol. I, Issue 2

Industry Insights

Digital Health Transactions—Are You Doing Your Due Diligence?

With investment in digital health start-ups growing exponentially in recent years, it is important that interested parties proceed with a transactional perspective attuned to the unique regulatory environment of this industry. Investors, strategic partners, and others looking to acquire a stake in the action are typically well versed in the standard business and legal due diligence conducted in connection with financings, M&A, joint ventures, and other transactional matters. However, the unique challenges facing digital health companies can often present unforeseen areas of regulatory and operational risk that may be overlooked in a standard due diligence review.

The legal issues faced by digital health companies can run the gamut but frequently involve complex analyses of state-based laws relating to the practice of a health care profession (e.g., corporate practice and fee-splitting prohibitions, licensure, standard of practice, e-prescribing, and informed consent) as well as federal and state laws relating to the privacy and security of health data, fraud and abuse, FDA oversight, and product liability. Companies operating in multiple states will often be required to comply with varying and, in some cases, vague or conflicting laws and regulations across such states. These laws can not only create significant potential liability for the unwary, they can also affect the financial assessment and value of a target company to the extent the company will need to modify its operations or be restructured to comply with such laws. 

Given the complex and rapidly evolving regulatory requirements implicated in the digital health arena, it is not uncommon for these emerging companies, despite their best intentions, to nonetheless fail to achieve compliance with many of such requirements or otherwise not be aware of how the requirements may apply. 

As a result, it is critical for investors, strategic partners, and others to identify these regulatory considerations during the due diligence process as a means not only to understand the potential liabilities a target company may face, but also to determine whether the target should be required to modify its operations or structure pre- or post-closing of the transaction.

Federal Features

EHR Programs—Last month, the Centers for Medicare & Medicaid Services ("CMS") and the Office of the National Coordinator for Health Information Technology ("ONC") issued their latest updates to federal initiatives promoting greater utilization of electronic health records ("EHRs"). CMS issued a proposed rule to implement Stage 3 of the Medicare and Medicaid EHR Incentive Programs, which encourages meaningful use of EHRs in clinical settings. Stage 3 will require most participating providers to submit clinical quality measurement data beginning in 2018. ONC's new certification criteria for EHR technology (2015 Edition) focuses on interoperability and promoting enhanced data portability, transitions of care, and application programming interface, or API, capabilities.

Telehealth Legislation—On April 21, 2015, the technology subcommittee of the Senate Committee on Commerce, Science & Transportation held a hearing on "Advancing Telehealth Through Connectivity," which focused on efforts by private sector and government entities to advance digital health, particularly in rural areas. Subcommittee member Roger Wicker (R-MS) indicated his plans to reintroduce the Telehealth Enhancement Act, a bill that would expand Medicare coverage for hospital telehealth services and allow accountable care organizations to seek Medicare Advantage reimbursement for telehealth and remote patient-monitoring services. The bill was not passed during the previous Congress.

21st Century Cures Act—Proposed legislation, titled the 21st Century Cures Act, aims to accelerate the discovery, development, and delivery of innovative medical therapies. According to an original discussion document by the House Energy & Commerce Committee, the bill would allow the Secretary of Health and Human Services to waive certain restrictions on Medicare coverage of telehealth services, including the originating site requirements, geographic limitations, and type-of-provider restrictions. However, recent reports from industry sources indicate lawmakers are planning to remove these telehealth provisions from the bill. Although an updated discussion document has not yet been released, the House Subcommittee on Health is scheduled to hold a legislative hearing on the bill on April 30, 2015.

VA Telehealth—The Department of Veterans Affairs ("VA") recently submitted its fiscal year 2016 budget, proposing to earmark $1.2 billion specifically for telehealth efforts, a nearly 10 percent increase from the prior year. The VA plans to expand telehealth operations to include audiology, intensive care, mental health, pathology, and radiology.

State Summaries

Interstate Medical Licensure CompactThe Interstate Medical License Compact (the "Compact") has now been adopted by six states, including Utah, Idaho, West Virginia, and Montana, which have passed enabling legislation since our last Update. By its own terms, the Compact must be enacted in at least seven states to become effective. Eleven other states have introduced enacting legislation. Follow the status of these bills and learn about the Compact at www.licenseportability.org

Arkansas—On April 1, 2015, Arkansas enacted the Telemedicine Act, which requires providers using telemedicine to (i) be licensed in Arkansas (except for episodic consultation services) and (ii) have an existing professional relationship with the patient based on a prior in-person examination (except for certain provider consultations and cross-coverage arrangements with the patient's regular treating professional). Effective January 1, 2016, the Act also requires certain health benefit plans to cover services provided using telemedicine on parity with coverage for in-person services.

Idaho—Last month, Idaho's governor signed the Idaho Telehealth Access Act into law. The Act, effective July 1, 2015, allows a provider to establish a provider–patient relationship using two-way audio and visual interaction, as long as the applicable standard of care is satisfied in each instance. A provider with an established provider–patient relationship (including as established through real-time video and audio engagement) may prescribe noncontrolled substances using telehealth services. The law also includes a specific informed consent requirement.

Mississippi—On March 23, 2015, the Mississippi Board of Medical Licensure proposed an amendment to its regulations, which would define "telemedicine" as "secure videoconferencing or store and forward technology" and sets standards for telehealth providers, including a specific list of components for informed consent. Notably, the proposed rule would require physicians providing telemedicine services in Mississippi to establish a formal agreement with a Mississippi-based health entity that can manage any needs for in-person care arising from the telemedicine examination.

Tennessee—HB 699 awaits the governor's approval. If signed, the legislation would establish an equal standard of care among services provided by both telemedicine and traditional in-person methods, effective July 1, 2015. Notably, the legislation prohibits any health care board or licensing entity from establishing a more restrictive standard of professional practice for services furnished by telehealth.

Texas—This month, the Texas Medical Board adopted rules  amending its Telemedicine Rules (TX Admin. Code, 22, Chapter 174) and its Disciplinary Guidelines (TX Admin. Code, 22, Chapter 190). The amendments (i) expanded the options for providing "telemedicine medical services" for mental health patients to allow for some services at a patient's home regardless of an in-person evaluation and (ii) clarified the Board's requirements on establishing a provider–patient relationship to require either (a) an in-person exam or (b) a face-to-face exam (for which a real-time video and audio modality would be appropriate). Reacting to significant press around the amendments, the Board issued a press release to provide assistance in interpreting the modified rule. Further, the American Telemedicine Association provided commentary on the rules and highlighted concerns about the confusing nature of the rules when proposed. The rules take effect June 3, 2015, unless the state legislature overturns them.

Reimbursement Review

State Reimbursement—Three states recently took action to enact reimbursement-related laws:

  • Last month, the governor of Colorado signed a telemedicine parity law restricting health benefit plans from requiring in-person contact between a provider and patient for coverage of telemedicine services. The law takes effect January 1, 2017.
  • Virginia amended its telemedicine parity law to modify the definition of "telemedicine services" to include "electronic technology or media, including interactive audio or video." Private health insurance must now accommodate a broader set of modalities other than video and audio.
  • Starting January 1, 2017, the state of Washington will require public and private health plans to cover services provided by telemedicine (real-time or store-and-forward) in cases where they would cover the same services in-person. Coverage for store-and-forward models requires a related face-to-face follow-up visit, which can be provided by telemedicine.

Global Happenings

India—In March 2015, the Union government announced that 41 government medical institutions will participate in a task force network aimed at addressing doctor shortages in rural India. The network will facilitate online consultations between medical colleges and peripheral health facilities, offering direct care to patients and educational resources for practitioners. Coinciding with this initiative, the India Medical Association has sponsored a "Telemedicine Day" to promote widespread adoption of digital solutions to the nation's health care challenges.

South Korea—The Ministry of Health & Welfare is facilitating a pilot program to expand telehealth services directly to patients in remote locations. Previously, South Korea restricted such services to consultations between health care practitioners at clinics. If the program is successful, it could be adopted as permanent law.

United Kingdom—The 2015 UK Budget included plans for significant investments in the "Internet of Things" ("IoT"), such as digital health. UK Chancellor of the Exchequer George Osborne also announced a £20 million funding boost in the budget for four health and social care information projects, including the "Connected Health Cities" initiative, which aims to assemble data, experts, and technology to generate new information that will help shape health and social care in England's northern regions. Some industry analysts predict that net revenue generated from IoT services could range from £800 billion to £1.5 trillion by 2020, and a significant aspect of this would be in health care services. Recent research published in the British Medical Journal found that using telehealth devices to monitor patients' health reduced hospital admissions by 18 percent and deaths by 46 percent (compared with usual care). The UK government's announcements are therefore part of a broader policy agenda to institutionalize digital technologies in health care services. In the past year, the National Health Service has been subject to significant cutbacks in funding, and digital technology is widely seen as a means to partly address the funding gap.

Upcoming Events

May 3–5, 2015: Scott Edelstein and Alexis Gilroy will speak at the American Telemedicine Association's Annual Meeting in a program titled Telehealth Partnering in US & Abroad—A Look at Viable Strategies & Legal Considerations. Doug Pearson, Bruce Olcott, and Chris Mikson will speak at a pre-conference session titled Digital Health in Transition: Regulatory Insights for Product Developers.

The content of this article is intended to provide a general guide to the subject matter. Specialist advice should be sought about your specific circumstances.

To print this article, all you need is to be registered on Mondaq.com.

Click to Login as an existing user or Register so you can print this article.

Authors
Kevin D. Lyles
Similar Articles
Relevancy Powered by MondaqAI
 
In association with
Related Topics
 
Similar Articles
Relevancy Powered by MondaqAI
Related Articles
 
Related Video
Up-coming Events Search
Tools
Print
Font Size:
Translation
Channels
Mondaq on Twitter
 
Register for Access and our Free Biweekly Alert for
This service is completely free. Access 250,000 archived articles from 100+ countries and get a personalised email twice a week covering developments (and yes, our lawyers like to think you’ve read our Disclaimer).
 
Email Address
Company Name
Password
Confirm Password
Position
Mondaq Topics -- Select your Interests
 Accounting
 Anti-trust
 Commercial
 Compliance
 Consumer
 Criminal
 Employment
 Energy
 Environment
 Family
 Finance
 Government
 Healthcare
 Immigration
 Insolvency
 Insurance
 International
 IP
 Law Performance
 Law Practice
 Litigation
 Media & IT
 Privacy
 Real Estate
 Strategy
 Tax
 Technology
 Transport
 Wealth Mgt
Regions
Africa
Asia
Asia Pacific
Australasia
Canada
Caribbean
Europe
European Union
Latin America
Middle East
U.K.
United States
Worldwide Updates
Registration (you must scroll down to set your data preferences)

Mondaq Ltd requires you to register and provide information that personally identifies you, including your content preferences, for three primary purposes (full details of Mondaq’s use of your personal data can be found in our Privacy and Cookies Notice):

  • To allow you to personalize the Mondaq websites you are visiting to show content ("Content") relevant to your interests.
  • To enable features such as password reminder, news alerts, email a colleague, and linking from Mondaq (and its affiliate sites) to your website.
  • To produce demographic feedback for our content providers ("Contributors") who contribute Content for free for your use.

Mondaq hopes that our registered users will support us in maintaining our free to view business model by consenting to our use of your personal data as described below.

Mondaq has a "free to view" business model. Our services are paid for by Contributors in exchange for Mondaq providing them with access to information about who accesses their content. Once personal data is transferred to our Contributors they become a data controller of this personal data. They use it to measure the response that their articles are receiving, as a form of market research. They may also use it to provide Mondaq users with information about their products and services.

Details of each Contributor to which your personal data will be transferred is clearly stated within the Content that you access. For full details of how this Contributor will use your personal data, you should review the Contributor’s own Privacy Notice.

Please indicate your preference below:

Yes, I am happy to support Mondaq in maintaining its free to view business model by agreeing to allow Mondaq to share my personal data with Contributors whose Content I access
No, I do not want Mondaq to share my personal data with Contributors

Also please let us know whether you are happy to receive communications promoting products and services offered by Mondaq:

Yes, I am happy to received promotional communications from Mondaq
No, please do not send me promotional communications from Mondaq
Terms & Conditions

Mondaq.com (the Website) is owned and managed by Mondaq Ltd (Mondaq). Mondaq grants you a non-exclusive, revocable licence to access the Website and associated services, such as the Mondaq News Alerts (Services), subject to and in consideration of your compliance with the following terms and conditions of use (Terms). Your use of the Website and/or Services constitutes your agreement to the Terms. Mondaq may terminate your use of the Website and Services if you are in breach of these Terms or if Mondaq decides to terminate the licence granted hereunder for any reason whatsoever.

Use of www.mondaq.com

To Use Mondaq.com you must be: eighteen (18) years old or over; legally capable of entering into binding contracts; and not in any way prohibited by the applicable law to enter into these Terms in the jurisdiction which you are currently located.

You may use the Website as an unregistered user, however, you are required to register as a user if you wish to read the full text of the Content or to receive the Services.

You may not modify, publish, transmit, transfer or sell, reproduce, create derivative works from, distribute, perform, link, display, or in any way exploit any of the Content, in whole or in part, except as expressly permitted in these Terms or with the prior written consent of Mondaq. You may not use electronic or other means to extract details or information from the Content. Nor shall you extract information about users or Contributors in order to offer them any services or products.

In your use of the Website and/or Services you shall: comply with all applicable laws, regulations, directives and legislations which apply to your Use of the Website and/or Services in whatever country you are physically located including without limitation any and all consumer law, export control laws and regulations; provide to us true, correct and accurate information and promptly inform us in the event that any information that you have provided to us changes or becomes inaccurate; notify Mondaq immediately of any circumstances where you have reason to believe that any Intellectual Property Rights or any other rights of any third party may have been infringed; co-operate with reasonable security or other checks or requests for information made by Mondaq from time to time; and at all times be fully liable for the breach of any of these Terms by a third party using your login details to access the Website and/or Services

however, you shall not: do anything likely to impair, interfere with or damage or cause harm or distress to any persons, or the network; do anything that will infringe any Intellectual Property Rights or other rights of Mondaq or any third party; or use the Website, Services and/or Content otherwise than in accordance with these Terms; use any trade marks or service marks of Mondaq or the Contributors, or do anything which may be seen to take unfair advantage of the reputation and goodwill of Mondaq or the Contributors, or the Website, Services and/or Content.

Mondaq reserves the right, in its sole discretion, to take any action that it deems necessary and appropriate in the event it considers that there is a breach or threatened breach of the Terms.

Mondaq’s Rights and Obligations

Unless otherwise expressly set out to the contrary, nothing in these Terms shall serve to transfer from Mondaq to you, any Intellectual Property Rights owned by and/or licensed to Mondaq and all rights, title and interest in and to such Intellectual Property Rights will remain exclusively with Mondaq and/or its licensors.

Mondaq shall use its reasonable endeavours to make the Website and Services available to you at all times, but we cannot guarantee an uninterrupted and fault free service.

Mondaq reserves the right to make changes to the services and/or the Website or part thereof, from time to time, and we may add, remove, modify and/or vary any elements of features and functionalities of the Website or the services.

Mondaq also reserves the right from time to time to monitor your Use of the Website and/or services.

Disclaimer

The Content is general information only. It is not intended to constitute legal advice or seek to be the complete and comprehensive statement of the law, nor is it intended to address your specific requirements or provide advice on which reliance should be placed. Mondaq and/or its Contributors and other suppliers make no representations about the suitability of the information contained in the Content for any purpose. All Content provided "as is" without warranty of any kind. Mondaq and/or its Contributors and other suppliers hereby exclude and disclaim all representations, warranties or guarantees with regard to the Content, including all implied warranties and conditions of merchantability, fitness for a particular purpose, title and non-infringement. To the maximum extent permitted by law, Mondaq expressly excludes all representations, warranties, obligations, and liabilities arising out of or in connection with all Content. In no event shall Mondaq and/or its respective suppliers be liable for any special, indirect or consequential damages or any damages whatsoever resulting from loss of use, data or profits, whether in an action of contract, negligence or other tortious action, arising out of or in connection with the use of the Content or performance of Mondaq’s Services.

General

Mondaq may alter or amend these Terms by amending them on the Website. By continuing to Use the Services and/or the Website after such amendment, you will be deemed to have accepted any amendment to these Terms.

These Terms shall be governed by and construed in accordance with the laws of England and Wales and you irrevocably submit to the exclusive jurisdiction of the courts of England and Wales to settle any dispute which may arise out of or in connection with these Terms. If you live outside the United Kingdom, English law shall apply only to the extent that English law shall not deprive you of any legal protection accorded in accordance with the law of the place where you are habitually resident ("Local Law"). In the event English law deprives you of any legal protection which is accorded to you under Local Law, then these terms shall be governed by Local Law and any dispute or claim arising out of or in connection with these Terms shall be subject to the non-exclusive jurisdiction of the courts where you are habitually resident.

You may print and keep a copy of these Terms, which form the entire agreement between you and Mondaq and supersede any other communications or advertising in respect of the Service and/or the Website.

No delay in exercising or non-exercise by you and/or Mondaq of any of its rights under or in connection with these Terms shall operate as a waiver or release of each of your or Mondaq’s right. Rather, any such waiver or release must be specifically granted in writing signed by the party granting it.

If any part of these Terms is held unenforceable, that part shall be enforced to the maximum extent permissible so as to give effect to the intent of the parties, and the Terms shall continue in full force and effect.

Mondaq shall not incur any liability to you on account of any loss or damage resulting from any delay or failure to perform all or any part of these Terms if such delay or failure is caused, in whole or in part, by events, occurrences, or causes beyond the control of Mondaq. Such events, occurrences or causes will include, without limitation, acts of God, strikes, lockouts, server and network failure, riots, acts of war, earthquakes, fire and explosions.

By clicking Register you state you have read and agree to our Terms and Conditions